Quotient Diagnostics Overview

  • Founded

  • 2003

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 19

Employees
  • Latest Deal Type

  • M&A

  • Latest Deal Amount

  • $8.05M

Quotient Diagnostics General Information

Description

Developer of immunohematology products. The company develops testing technologies for the diagnosis and treatment of diabetes and associated diseases. It also provides point-of-care devices for glycated hemoglobin measurement.

Contact Information

Website
www.quotientdiagnostics.co.uk
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Acquirer
EKF Diagnostics Holdings
Primary Office
  • Russell House
  • Molesey Road, Walton-on-Thames
  • Surrey KT12 3PE
  • England, United Kingdom
+44 01932 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quotient Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 04-Oct-2010 $8.05M 00.00 00.000 Completed Generating Revenue
6. Debt - General 01-Feb-2010 00.00 Completed Generating Revenue
5. Later Stage VC 16-Jul-2009 00.000 00.00 Completed Generating Revenue
4. Later Stage VC 01-Apr-2008 000 00.000 Completed Generating Revenue
3. Early Stage VC 21-Jul-2006 00000 00.000 00.000 Completed Product Development
2. Early Stage VC 16-Aug-2005 $1.45M $2.65M Completed Product Development
1. Early Stage VC 18-Jul-2005 $1.2M $1.2M Completed Product Development
To view Quotient Diagnostics’s complete valuation and funding history, request access »

Quotient Diagnostics Patents

  • 10

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Quotient Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2005164-A2 Fluorescent assay Active 31-Mar-2006 0000000000
EP-2005164-B1 Fluorescent assay Active 31-Mar-2006 0000000000
ES-2377232-T3 Fluorescent analysis Active 31-Mar-2006 0000000000
GB-2436681-A Fluorescent assay Active 31-Mar-2006 0000000000 0
GB-0606450-D0 Fluorescent assay Active 31-Mar-2006 G01N33/721
To view Quotient Diagnostics’s complete patent history, request access »

Quotient Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quotient Diagnostics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BBI Holdings Corporation Minority 000 0000 000000 0
GEIF Ventures Venture Capital Minority 000 0000 000000 0
IQ Capital Partners Venture Capital Minority 000 0000 000000 0
Italian Angels for Growth Angel Group Minority 000 0000 000000 0
London Business Angels Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »

Ready to get started?

Request a free trial